Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nanotechnology

• Publication date

  2012-06-29

• Fields of study

  Materials Science, Medicine, Physics, Chemistry

• Identifiers
  DOI 10.1088/0957-4484/23/25/255102PMID 22652439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spatiotemporal profiles of transcallosal connections in rat insular cortex revealed by in vivo optical imaging.

  2012cited by this paper
• A review of NIR dyes in cancer targeting and imaging.

  2011cited by this paper
• Prodrug design for brain delivery of small- and medium-sized neuropeptides.

  2011cited by this paper
• The use of fluorescent dyes and probes in surgical oncology.

  2010cited by this paper
• Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye

  2010cited by this paper
• Optical small animal imaging in the drug discovery process.

  2010cited by this paper
• A Comparative Study of Transfection Efficiency between Liposomes, Immunoliposomes and Brain-specific Immunoliposomes

  2010cited by this paper
• In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes

  2010cited by this paper
• Nanotechnology for delivery of drugs to the brain for epilepsy

  2009cited by this paper
• The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.

  2009cited by this paper
• PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation.

  2009cited by this paper
• Nanoparticles in Cancer

  2008cited by this paper
• Delivery of nanoparticles to the brain detected by fluorescence microscopy.

  2008cited by this paper
• PEGylation: an approach for drug delivery. A review.

  2008cited by this paper
• PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies.

  2008cited by this paper
• Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

  2007cited by this paper
• Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.

  2007cited by this paper
• Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.

  2007cited by this paper
• Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation.

  2007cited by this paper
• Oleic acid coating on the monodisperse magnetite nanoparticles

  2006cited by this paper
• Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles.

  2006cited by this paper
• Application of nanoparticles for the delivery of drugs to the brain

  2005cited by this paper
• The blood-brain barrier: Bottleneck in brain drug development

  2005cited by this paper
• Targeting liposomes with protein drugs to the blood-brain barrier in vitro.

  2005cited by this paper
• Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery

  2004cited by this paper
• Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.

  2004cited by this paper
• Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

  2004cited by this paper
• [Drug delivery to the brain with nanoparticles].

  2003cited by this paper
• Rhodamine 123 Requires Carrier-Mediated Influx for Its Activity as a P-Glycoprotein Substrate in Caco-2 Cells

  2003cited by this paper
• Pegnology: a review of PEG-ylated systems.

  2002cited by this paper
• Nanoparticles in cancer therapy and diagnosis.

  2002cited by this paper
• PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.

  2001cited by this paper
• Transition from superparamagnetism to ferromagnetic single-domain in a Heisenberg model for nano-cluster magnetic system

  2000cited by this paper
• Transition from Superparamagnetism to Ferromagnetic Single-Domain in a Heisenberg Model for Nano-cluster Magnetic System

  2000cited by this paper
• P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

  2000cited by this paper
• Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

  1998cited by this paper
• Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means

  1998cited by this paper
• The blood‐brain barrier

  1993cited by this paper
• A strategy for delivering peptides into the central nervous system by sequential metabolism.

  1992cited by this paper
• Improved brain delivery of AZT using a glycosyl phosphotriester prodrug.

  1992cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

  1987cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• The blood-brain barrier in vitro.

  1985cited by this paper
• Particle Size Measurement

  1965cited by this paper
• Indocyanine green: physical and physiologic properties.

  1960cited by this paper
• Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.

  1960cited by this paper

• Enhancement of mitochondrial function using NO releasing nanoparticles; a potential approach for therapy of Alzheimer's diseases.

  2023cites this paper
• Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer

  2022cites this paper
• Fluorescently Labeled PLGA Nanoparticles for Visualization In Vitro and In Vivo: The Importance of Dye Properties

  2021cites this paper
• Manipulation

  2019cites this paper
• Organic polymer particles for biomedical applications

  2019cites this paper
• Nanosystems and magnetism

  2018cites this paper
• Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.

  2018cites this paper
• Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier

  2017cites this paper
• The Significance of Nanomedicine in Brain-Targeted Drug Delivery: Crossing Blood-Brain Barriers

  2017cites this paper
• Nanostructures in Drug Delivery

  2016cites this paper
• Rhodamine 123 (RH 123)

  2015cites this paper
• Recent trends in preparation of poly(lactide- co -glycolide) nanoparticles by mixing polymeric organic solution with antisolvent

  2015cites this paper
• Bench-to-bedside translation of magnetic nanoparticles.

  2014cites this paper
• Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.

  2014cites this paper
• Mannosylated nanoparticles for targeted delivery of amphotericin B towards visceral leishmaniasis

  2012cites this paper
• In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles

  2012cites this paper